In this retrospective cohort study designed to assess long-term safety outcomes of drug-coated devices (DCDs) versus ...

What if you'd invested in Boston Scientific (BSX) ten years ago? It may not have been easy to hold on to BSX for all that time, but if you did, how much would your investment be worth today? With that ...

The landscape of coronary and pulmonary vascular medicine is undergoing a paradigm shift, fueled by breakthroughs in molecular biology, imaging, and ...